PubRank

T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Clinical Trial ID NCT01860937

PubWeight™ 16.19‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01860937

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 2014 2.84
2 Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int J Hematol 2013 1.64
3 Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014 1.61
4 Engineered T cells: the promise and challenges of cancer immunotherapy. Nat Rev Cancer 2016 1.51
5 Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies. Cancer Gene Ther 2015 0.97
6 Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology 2014 0.96
7 CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL). Ther Adv Hematol 2015 0.95
8 A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer. J Transl Med 2015 0.89
9 Novel agents for the treatment of childhood acute leukemia. Ther Adv Hematol 2015 0.87
10 Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. Leukemia 2014 0.86
11 Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances. Ther Adv Hematol 2015 0.82
12 Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncol 2014 0.78
13 Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors. World J Stem Cells 2015 0.78
14 Using gene therapy to manipulate the immune system in the fight against B-cell leukemias. Expert Opin Biol Ther 2015 0.77
15 Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology. Pediatr Blood Cancer 2015 0.75
Next 100